Agilent and Incyte Collaborate on CDx for Hematology and Oncology
Agilent will expand its CDx portfolio with novel biomarkers and Incyte will leverage Agilent’s expertise in IVD assay development.
Read MorePosted by Andy Lundin | Jan 31, 2024 | Cancer, Hematology & Serology |
Agilent will expand its CDx portfolio with novel biomarkers and Incyte will leverage Agilent’s expertise in IVD assay development.
Read MorePosted by Andy Lundin | Jan 4, 2024 | Hematology Instrumentation, Lab Automation |
The platform offers a flexible modular hematology solution that is fully scalable with myriad configurations for mid to large-scale labs.
Read MorePosted by Andy Lundin | Dec 7, 2023 | Hematology Instrumentation |
The hematology analyzer provides patient-side results to screen for conditions including infection, leukemia, and other blood-related cancers.
Read MorePosted by Chris Wolski | Jun 8, 2023 | Hematology & Serology |
The May/June 2023 Tech Guide that appears in Clinical Lab Products (CLP) features a wide-range of products from top laboratory providers.
Read MorePosted by Andy Lundin | Apr 3, 2023 | Hematology Instrumentation |
Ad Astra Diagnostics submitted a 510(k) application to the FDA for its QScout RLD rapid-result hematology system.
Read More